FDA May Change Rules for Diabetes Drugs
Posted on: Sunday, 29 June 2008, 03:00 CDT
The U.S. Food and Drug Administration is considering new standards for drugs designed to treat diabetes, The Wall Street Journal reports.
The agency is considering benchmarks that would require pharmaceutical companies to prove the drugs reduce the risk of heart attack or increase the life span of diabetics, the newspaper said. Current benchmarks like reduction in blood sugar are easier to measure.
Two large scientific studies found no evidence that aggressive reduction in blood sugar levels increases diabetics' life expectancy or cardiovascular health, the newspaper said.
The FDA is also considering requiring pharmaceutical companies to show that diabetes drugs currently on the market do not increase the risk of heart disease.
The agency plans a two-day meeting beginning Tuesday to discuss whether standards should be changed. It will involve both FDA scientists and outside experts on diabetes.
Source: United Press International
Related Articles
- Some hypertension drugs risky in early pregnancy
- Three More Provinces Approve Costly Breast Cancer Drug Herceptin
- Two More Provinces Approve Costly Breast Cancer Drug Herceptin
- Safety of Three Asthma Drugs is Considered
- Cold Drug Curbs Considered in Meth Fight
- National Cold Drug Curbs Considered in Meth Fight
- New Drugs Offer Hope for Those With Macular Degeneration
- San Diego Drug Firm Suffers Setback on Experimental Leukemia Drug
- Antiplatelet Therapy
- Study Warns of Drugs' Diabetes Risk
 |
 |
User Comments (0)
RSS Feeds